David P Steensma1, Robert A Kyle. 1. Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA. steensma.david@mayo.edu
Abstract
BACKGROUND: The kidneys are commonly injured in plasma cell dyscrasias. METHODS: We reviewed the pertinent medical literature related to the historical development of clinical nephrology and diagnostic renal pathology; early case reports of patients with plasma cell disorders; and historical descriptions of multiple myeloma, amyloidosis, and the renal disorders that are associated with these conditions. RESULTS: Medieval uroscopists recognized proteinuria, and in 1827 Richard Bright first linked proteinuria to both dropsy (edema) and the autopsy finding of chronically diseased, scarred kidneys. In the 1840s, Henry Bence Jones and William Macintyre described a peculiar form of proteinuria in a middle-aged English grocer with fragile, tumor-riddled bones; this proteinuria became known as 'Bence Jones type'. It was initially believed that Bence Jones proteins were harmless to the kidney, but after 1899 (when myeloma cast nephropathy was recognized), investigators observed numerous renal injury patterns associated with plasma cell dyscrasias. Gross observations of 'waxy degeneration' or 'lardaceous change' in organs including the kidney yielded to the misnomer 'amyloid' in 1854, when iodine staining suggested to Rudolf Virchow that the strange material present in these conditions was a form of starch or cellulose. During the 20th century, biochemists and physicians carefully studied patients with myeloma, in order to better define the nature and structure of normal and pathological immunoglobulins. CONCLUSION: Historical understanding of the kidney in plasma cell disorders reflects developments in understanding of the anatomy and physiology of the kidneys in health and in disease.
BACKGROUND: The kidneys are commonly injured in plasma cell dyscrasias. METHODS: We reviewed the pertinent medical literature related to the historical development of clinical nephrology and diagnostic renal pathology; early case reports of patients with plasma cell disorders; and historical descriptions of multiple myeloma, amyloidosis, and the renal disorders that are associated with these conditions. RESULTS: Medieval uroscopists recognized proteinuria, and in 1827 Richard Bright first linked proteinuria to both dropsy (edema) and the autopsy finding of chronically diseased, scarred kidneys. In the 1840s, Henry Bence Jones and William Macintyre described a peculiar form of proteinuria in a middle-aged English grocer with fragile, tumor-riddled bones; this proteinuria became known as 'Bence Jones type'. It was initially believed that Bence Jones proteins were harmless to the kidney, but after 1899 (when myeloma cast nephropathy was recognized), investigators observed numerous renal injury patterns associated with plasma cell dyscrasias. Gross observations of 'waxy degeneration' or 'lardaceous change' in organs including the kidney yielded to the misnomer 'amyloid' in 1854, when iodine staining suggested to Rudolf Virchow that the strange material present in these conditions was a form of starch or cellulose. During the 20th century, biochemists and physicians carefully studied patients with myeloma, in order to better define the nature and structure of normal and pathological immunoglobulins. CONCLUSION: Historical understanding of the kidney in plasma cell disorders reflects developments in understanding of the anatomy and physiology of the kidneys in health and in disease.
Authors: Nelson Leung; Frank Bridoux; Vecihi Batuman; Aristeidis Chaidos; Paul Cockwell; Vivette D D'Agati; Angela Dispenzieri; Fernando C Fervenza; Jean-Paul Fermand; Simon Gibbs; Julian D Gillmore; Guillermo A Herrera; Arnaud Jaccard; Dragan Jevremovic; Efstathios Kastritis; Vishal Kukreti; Robert A Kyle; Helen J Lachmann; Christopher P Larsen; Heinz Ludwig; Glen S Markowitz; Giampaolo Merlini; Peter Mollee; Maria M Picken; Vincent S Rajkumar; Virginie Royal; Paul W Sanders; Sanjeev Sethi; Christopher P Venner; Peter M Voorhees; Ashutosh D Wechalekar; Brendan M Weiss; Samih H Nasr Journal: Nat Rev Nephrol Date: 2019-01 Impact factor: 28.314